According to the National Medical Products Administration on July 11th, on July 10th, the National Medical Products Administration held an Innovation Medical Device Report Meeting to showcase the innovation and development of China's medical device industry and the achievements of the review and approval system reform, exchange and share experiences in the innovation, research, and development application of medical devices, and contribute to further promoting the highquality development of China's medical device industry.

On July 5, The State Council Information Office held a series of themed press conferences on "Authoritative Department Opening" to introduce the relevant situation of "Strengthening drug supervision and effectively ensuring the safety of drug use for the people". Xu Jinghe, deputy director of the State Drug Administration, introduced that in recent years, the State Drug Administration has taken innovative medical devices as the main focus, and has issued the "Special Review Procedures for Innovative Medical Devices" and "Medical device priority review".